Patient in end-stage renal disease candidate for a kidney transplant
Conditions
Brief summary
Iohexol clearance at 3 months
Detailed description
Proportion of dialysis dependency at 3 months, Proportion of patients presenting a delayed graft function at 7 days post transplantation, 24-hour proteinuria and 24-hour microalbuminuria at 3 months, Occurrence of hyperkalemia > 6 mmol/l at 7 days post transplantation, Length of initial hospital stay, Proportion of patients alive and glomerular filtration rate at 3 months 1 year, 3 years, 10 years post transplantation, Proportion of patients with biopsy-proven acute rejection at 3 months post tranplantation
Interventions
DRUGOMNIPAQUE 300 mg d'I/ml
DRUGsolution injectable
DRUGGélules de lactose monohydraté additionné de carmin de cochenille
DRUGINSPRA 50 mg
DRUGcomprimé pelliculé
Sponsors
CHRU De Nancy
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Iohexol clearance at 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of dialysis dependency at 3 months, Proportion of patients presenting a delayed graft function at 7 days post transplantation, 24-hour proteinuria and 24-hour microalbuminuria at 3 months, Occurrence of hyperkalemia > 6 mmol/l at 7 days post transplantation, Length of initial hospital stay, Proportion of patients alive and glomerular filtration rate at 3 months 1 year, 3 years, 10 years post transplantation, Proportion of patients with biopsy-proven acute rejection at 3 months post tranplantation | — |
Countries
France
Outcome results
None listed